ArticleDiabetes care2023

Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors.

Michael P BancksPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.